user

Rethix

Research Services

View the employees at

Rethix

Overview

rEthix, Inc. is the world's first liaison research organization that bridges ethics with research, promoting access to clinical research and innovative therapies for all while ensuring the safety and well-being of research participants and the integrity of the research process. We work with sponsors, research sites, and patients to facilitate the initiation of clinical research projects in compliance with the highest ethical and regulatory standards. Our experience working with regulatory agencies such as COFEPRIS, FDA, and EMA allows for faster access to medical treatments and innovative therapies by conducting clinical trials in parallel across different countries. Our approach is unique in prioritizing ethical considerations and transparency throughout the research process. We believe that the research process should be cost-effective without compromising ethical principles or regulatory requirements. Our commitment to advancing medical knowledge and improving patient care through clinical research is unwavering. We ensure that access to clinical research and innovative therapies is available to everyone. At rEthix, Inc., we are constantly innovating to improve the clinical research process. We are training an AI with thousands of successful clinical protocols from clinicaltrials.gov to create a powerful clinical protocol development app. This app will be made available to any researcher, no matter how small or insignificant they are, who will be provided with a pathway to commercialize their discoveries and innovations. Additionally, we are developing a platform for thousands of clinical diagnostics CLIA labs across the USA to validate human fluid collection devices, promising to save labs hundreds of thousands of dollars in operational costs and increase sample volume. We also work hard to significantly reduce the initial cost of designing, running, and managing a clinical trial while maintaining ethical principles and regulatory compliance.